June 18, 2019September 18, 2024Product Defect Migliaccio & Rathod LLP Appointed to Help Lead Valsartan Litigation Migliaccio & Rathod LLP File Nationwide Class Action Complaint Against Major Pharmaceutical Companies for Contaminated Valsartan Sales and Are Appointed by Court […]
May 16, 2019September 18, 2024Product Defect Valsartan Carcinogenic Contaminants Investigation Migliaccio & Rathod LLP has filed a class action lawsuit against certain manufacturers of Valsartan, an angiotensin II receptor blocker used […]